biomedicina slovenica


re="Cancer" : 101-200

  1. Pavlin Darja; Čemažar Maja; Kamenšek Urška; Tozon Nataša; Pogačnik Azra; Serša Gregor
    Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma
    2009
  2. Pasanisi Patrizia; Primic-Žakelj Maja; Zadnik Vesna
    Oral contraceptive use and BRCA penetrance: #a #case-only study
    2009
  3. Kokalj-Vokač Nadja; Kodrič Tatjana; Erjavec Škerget Alenka; Zagorac Andreja; Takač Iztok
    Screening of TERC gene amplification as an additional genetic diagnostic test in detection of cervical preneoplastic lesions
    2009
  4. Mlakar Vid; Stražišar Mojca; Sok Mihael; Glavač Damjan
    Oligonucleotide DNA microarray profiling of lung adenocarcinoma revealed significant downregulation and deletions of vasoactive intestinal peptide receptor 1
    2009
  5. Korde Larissa A; Lusa Lara; McShane Lisa; Lebowitz Peter F; Lukes LuAnne; Camphausen Kevin; Parker Joel S; Swain Sandra M; Hunter Kent; Zujewski Jo Anne
    Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
    2009
  6. Rotar-Pavlič Danica; de Graaf Pim
    Chronic cancer care in primary care: emerging needs, emerging innovations
    2009
  7. Berginc Gašper; Bračko Matej; Ravnik-Glavač Metka; Glavač Damjan
    Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome
    2009
  8. Pompe-Kirn V; Primic-Žakelj M
    An epidemiological analysis of bladder cancer in Slovenia
    1987
  9. Ravnihar B; Pompe-Kirn V
    Multiple primary cancers as recorded by the cancer registry of Slovenia - a problem of reliability
    1974
  10. Zwitter M; Pompe-Kirn V; Primic-Žakelj M
    Pregnancy and Hodgkin's disease
    1989
  11. Pompe-Kirn V; Ferligoj A
    Solving the problem of small population based areas for the analysis of rare diseases by clustering with constraints methods
    1989
  12. Nicula Florian A.; Anttila Ahti; Neamtiu Luciana; Primic-Žakelj Maja; Tachezy Ruth; Chil Arkadiusz; Grce Magdalena; Kesić Vesna
    Challenges in starting organised screening programmes for cervical cancer in the member states of the European Union
    2009
  13. Ronco Guglielmo; van Ballegoijen Marjolein; Becker Nicolas; Rebolj Matejka; Primic-Žakelj Maja
    Process performance of cervical screening programmes in Europe
    2009
  14. Stare Janez
    Goodness of fit of relative survival regression models
    2009
  15. Stare Janez
    A new measure of explained variation for survival models
    2009
  16. Mlakar Vid; Berginc Gašper; Volavšek Metka; Štor Zdravko; Rems Miran; Glavač Damjan
    Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer
    2009
  17. Tomaževič Tanja; Jazbec Janez
    Controlled, randomised, double-blinded study of prevention and treatment of oralmucositis with propolis
    2009
  18. Bešić Nikola; Vidergar-Kralj Barbara; Žagar Ivana
    Radioiodine in therapy of patients with Hürthle cell carcinoma of the thyroid
    2009
  19. Snoj Nataša; Bedard Philippe L.; De Azambuja Evandro; Cardoso Fatima; Piccart Martine
    Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
    2009
  20. Škof Erik; Reberšek Martina; Hlebanja Zvezdana; Ocvirk Janja
    Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial
    2009
  21. Tevž Gregor; Pavlin Darja; Kamenšek Urška; Kranjc Simona; Vidic Suzana; Cör Andrej; Serša Gregor; Čemažar Maja
    Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression
    2008
  22. Golouh R; Čufer T; Sadikov A; Nussdorfer P; Usher PA; Brunner N; Schmitt M; Lesche R; Maier S; Timmermans M; Foekens JA; Martens JW
    The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study
    2008
  23. Thurlimann Beat; Price Karen N; Gelber Richard D; Holmberg Stig B; Crivellari Diana; Colleoni Marco; Collins John; Forbes John F; Castiglione-Gertsch Monica; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
    2009
  24. Zhang Yi; Sieuwerts Anieta M; McGreevy Michelle; Casey Graham; Čufer Tanja; Paradiso Angelo; Harbeck Nadia; Span Paul N; Hicks David G; Golouh Rastko
    The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
    2009
  25. Pagani O; Gelber S; Simoncini E; Castiglione-Gertsch M; Price KN; Gelber RD; Holmberg SB; Crivellari D; Lindtner J; Čufer T
    Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93
    2009
  26. Cardoso F; Bedard PL; Winer EP; Pagani O; Senkus-Konefka E; Fallowfield LJ; Kyriakides S; Costa A; Čufer T; Albain KS
    International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy
    2009
  27. Snoj N; Čufer T
    Two faces of screen detected cancers
    2009
  28. Ravnik M; Sadikov A; Snoj N; Nussdorfer P; Čufer T
    Validation of Adjuvant online on Slovenian collective of hormone receptor (HR) positive early breast cancer patients
    2009
  29. Stražišar Mojca; Glavač Damjan
    Genetics of sporadic and hereditary colorectal cancer: implications for molecular diagnostics and genetic counseling
    2009
  30. Kočevar N; Odreman-Macchioli F; Vindigni A; Frković-Grazio S; Balažic J; Komel R
    Identification of biomarkers in gastric edenocarcinoma
    2009
  31. Karina M; Čufer Tanja
    Preliminary safety data of the EORTC 10994/BIG 00-01 neoadjuvant trial comparing 3 cycles of docetaxel followed by 3 cycles of epirubicin-docetaxel versus 6 cycles of FEC 100 in patients with locally advanced/inflammatory or large operable breast cancer
    2006
  32. Golouh Rastko; Čufer Tanja; Sadikov A; Nusdorfer P; Usher P; Bruenner N; Schmitt M; Harbeck N; Lesche R; Meier S
    Stathmin-1 protein expression is associated with disease recurrence in tamoxifen-treated steroid hormone receptor positive early breast cancer: an immunohistochemical study
    2006
  33. Uršič-Vrščaj Marjetka; Rakar Stelio; Možina Andrej; Takač Iztok; Smrkolj Špela
    Clinical audit of patients with cervical cancer
    2006
  34. Macias Vicky; Geynisman Julia; Frković-Grazio Snježana; Bračko Matej; Sušnik Barbara; Lu Yi; Kajdacsy-Balla Andre A; Lindholm Paul F
    Tissue factor (TF) expression in primary invasive breast cancer correlates with tumor size and grade but not with outcome
    2009
  35. Žgajnar J
    Breast conserving surgery
    2003
  36. Žgajnar Janez
    Surgical management of nonpalpable breast lesions
    2003
  37. Strojan Primož; Zadravec-Zaletel Lorna; Anžič Jožica; Korenjak Roman; Jereb Berta
    The role of radiotherapy in the treatment of childhood intracranial germinoma: long-term survival and late effects
    2006
  38. Chuang Shu-Chun; Pompe-Kirn Vera
    Risk of second primary cancer among esophageal cancer patients: #a #pooled analysis of 13 cancer registries
    2008
  39. Velenšek Veronika; Mazič Uroš; Kržišnik Ciril; Demšar Damjan; Jazbec Janez; Jereb Berta
    Cardiac damage after treatment of childhood cancer: a long-term follow-up
    2008
  40. Munch-Petersen Birgitte; Piškur Jure
    Deoxynucleoside kinases and their potential role in deoxynucleoside cytotoxicity
    2006
  41. Stražišar M; Mlakar V; Rott T; Glavač D
    Somatic alterations of the serine/threonine kinase LKB1 gene in squamous Cell (SCC) and large cell (LCC) lung carcinoma
    2009
  42. Lusa Lara
    Challenges in transporting multigene classifiers to the clinic
    2008
  43. Celhar Teja; Geršak Ksenija; Ovčak Zdenka; Sedmak Boris; Mlinarič-Raščan Irena
    The presence of the CYP11A1 (TTTTA)6 allele increases the risk of biochemical relapse in organ confined and low-grade prostate cancer
    2008
  44. Ravnihar B; Pompe-Kirn V
    Yugoslavia, Slovenia
    1976
  45. Chuang Shu-Chun; Pompe-Kirn Vera
    Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries
    2008
  46. Stražišar Mojca; Mlakar Vid; Glavač Damjan
    LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinoma
    2009
  47. Čufer Tanja; Pajk Bojana; Borštnar Simona
    Individualised systemic treatment
    2006
  48. Viale Giuseppe; Golouh Rastko
    Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
    2008
  49. Pavlin Darja; Tozon Nataša; Serša Gregor; Pogačnik Azra; Čemažar Maja
    Efficient electrotransfection into canine muscle
    2008
  50. Korošec Branka; Glavač Damjan; Volavšek Metka; Ravnik-Glavač Metka
    Alterations in genes encoding sarcoplasmic-endoplasmic reticulum Ca(2+) pumps in association with head and neck squamous cell carcinoma
    2008
  51. Berne S; Španinger K; Komel R; Debeljak N
    Molecular mechanism of recombinant human erythropoietin action on cancer cells
    2008
  52. Feldman Laurie; Jeong Jee-Yeong; Davis Kerry L; Socha Amanda L; Španinger Klemen; Sytkowski Arthur
    Role of the erythropoietin receptor in breast cancer pathobiology
    2008
  53. Lah-Turnšek Tamara; Duran-Alonso Beatriz M; Gole Boris; Kenig Saša; Pucer Anja; Ardebili Youssuf; Dolenc Vincenc
    SIgnalling of the lysosomal proteases cathepsins B and L in regulating glioma progression
    2008
  54. Filipič Metka; Plazar Janja; Žegura Bojana; Lah Tamara T; Groothuis Geny MM; Ferk Franziska; Huber Wolfgang W; Kansmueller Siegfried
    Xanthohumol from hop (Humulus lupulus L) and beer: a promisiing natural cancer preventive compound
    2008
  55. de Haas T; Hasselt N; Troost D; Caron H; Popović M; Zadravec-Zaletel L; Grajkowska W; Perek M; Osterheld MC; Ellison D
    Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression
    2008
  56. Omejc Mirko; Mekicar Jernej
    Computer analysis of lymph nodes in gastric cancer surgery
    2008
  57. Stražišar Mojca; Rott Tomaž; Glavač Damjan
    Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer
    2009
  58. Bizjak-Ogrinc Urška; Čufer Tanja; Pompe-Kirn Vera
    Survival of patients with invasive urinary bladder cancer in Slovenia regarding to stage of disease and treatment in years 1987-1997
    2007
  59. Pompe-Kirn V; Zakotnik B; Volk N; Benulič T; Škrk J
    Cancer patients survival in Slovenia, 1963-1990
    1995
  60. Ravnihar B; Pompe-Kirn V
    Experiences of the cancer registry in Slovenia
    1975
  61. Cappelletti V; Gariboldi M; De Cecco; Toffanin S; Reid JF; Lusa L; Bajetta E; Celio L; Greco M; Fabbri A; Pierotti MA; Daidone MG
    Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer
    2008
  62. Ravnik Maja; Takač Iztok; Arko Darja; Gorišek Borut; Čas-Sikošek Nina; Lampelj Maja; Ravnik Janez; Čufer Tanja
    Expression of invasive markers (uPA/PAI-1) in four different HER2, ER, PR subgroups of early breast cancer
    2008
  63. Lusa L
    Discovery and validation of cancer subtypes using high-throughput technologies
    2007
  64. Serša Gregor; Jarm Tomaž; Kotnik Tadej; Cör Andrej; Podkrajšek Maja; Šentjurc Marjeta; Miklavčič Damijan; Kadivec Maksimiljan; Kranjc Simona; Šečerov Ajra; Čemažar Maja
    Vascular disrupting action of electroporatin and electrochemotherapy with bleomycin in murine sarcoma
    2008
  65. Zielinski Christoph C.; Awada Ahmad; Cameron David A.; Čufer Tanja; Martin Miguel; Aapro Matti S.
    The impact of new European organisation for research and treatment of cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients
    2008
  66. Lusa Lara; Peissel Bernard; Manoukian Siranoush; Marchesi Edoardo; Radice Paolo; Pierotti Marco A; Gariboldi Manuela
    Re: Molecular basis for estrogen receptor alpha deficiency in BRCA 1-linked breast cancer
    2008
  67. Možina A; Uršič-Vrščaj M; Takač I; Meglič L; Smrkolj Š; Rakar S
    Clinical audit of patients with cervical cancer in Slovenia - data analysis for the year 2003 and 2004
    2006
  68. Meglič L; Možina A; Verdenik I
    Cytology quality in the national cervical screening program in Slovenia
    2006
  69. Frattini M; Gallino G; Signoroni S; Balestra D; Lusa L; Battaglia L; Sozzi G; Bertario L; Leo E; Pilotti S; Pierotti MA
    Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer
    2008
  70. Hočevar Marko; Auersperg Marija
    Use of serum thyroglobulin for monitoring the effect of chemotherapy and irradiation in differentiated thyroid cancer
    1995
  71. Auersperg Marija; Us-Krašovec Marija; Pogačnik Ana; Hočevar Marko; Palčič Branko; Garner D
    Vinblastine (VBL) in differentiated thyroid carcinoma (DTC) effect monitored by DNA measurements
    1995
  72. Debrakeleer S.; De Greve Jacques; Krajc Mateja; Sermijn E.; Fontaine C.; Goelen Guido; Bonduelle M.; Novaković Srdjan; Teugels Erik
    Germline mutation of the BARD1 ankyrin domain in a non-BRCA1/2 breast cancer family
    2006
  73. Možina Andrej; Uršič-Vrščaj Marjetka; Takač Iztok; Meglič Leon; Smrkolj Špela; Rakar Stelio
    Clinical audit of patients with cervical cancer in Slovenia - data analysis for the years 2003 and 2004
    2006
  74. Albreht Tit; McKee Martin; Alexe Delia-Marina; Coleman Michel P; Martin-Moreno Jose M
    Making progress against cancer
    2008
  75. Alexe Delia-Marina; Albreht Tit; McKee Martin; Coleman Michel P
    Responding to the challenge of cancer in Europe
    2008
  76. Rokavec Matjaž; Justenhoven Christina; Schroth Werner; Istrate Monica Adina; Haas Susanne; Fischer Hans-Peter; Vollmert Caren; Illig Thomas; Hamann Ute; Ko Yon-Dschun; Glavač Damjan; Brauch Hiltrud
    A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk
    2007
  77. Cataliotti L.; Čufer Tanja
    Guidelines on the standards for the training of specialised health professionals dealing with breast cancer
    2007
  78. Lusa Lara; Mc Shane Lisa M; Reid James F; De Cecco Loris; Ambrogi Federico; Biganzoli Elia; Gariboldi Manuela; Pierotti Marco A
    Challenges in projecting clustering results across gene expression profiling data sets
    2007
  79. Mezzanzanica Delia; Fabbi Marina; Bagnoli Marina; Staurengo Samantha; Losa Marco; Balladore Emanuela; Alberti Paola; Lusa Lara; Ditto Antonino; Ferrini Silvano
    Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients
    2008
  80. Debevec Lučka; Debeljak Andrej
    Outcomes of unselected routinely treated lung cancer patients
    2008
  81. Menvielle G; Kunst AE; Stirbu I; Strand BH; Borrell C; Regidor E; Leclerc A; Esnaola S; Bopp M; Lundberg O; Artnik B; Costa G; Deboosere P; Martikainen P; Mackenbach JP
    Educational differences in cancer mortality among women and men: a gender pattern that differs across Europe
    2008
  82. Reid James F; Lusa Lara; De Cecco Loris; Coradini Danila; Veneroni Silvia; Daidone Maria Grazia; Gariboldi Manuela; Pierotti Marco A
    Re:Limits of predictive models using microarray data for breast cancer clinical treatment outcome: resoponse
    2005
  83. Reid James F; Lusa Lara; De Cecco Loris; Coradini Danila; Veneroni Silvia; Daidone Maria Grazia; Gariboldi Manuella; Pierotti Marco A
    Limits of predictive models using microarray data for breast cancer clinical treatment outcome
    2005
  84. Lusa Lara; McShane Lisa M; Reid James F; De Cecco Loris; Ambrogi Federico; Biganzoli Elia; Gariboldi Manuela; Pierotti Marco A
    Challenges in projecting clustering results across gene expression-profiling datasets
    2007
  85. Injac Rade; Perše Martina; Bošković Marija; Djordjević Milić Vukosava; Djordjević Aleksandar; Hvala Anastazija; Cerar Anton; Štrukelj Borut
    Cardioprotective effects of fullerenol c60(oh)24 on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm
    2008
  86. Eržen M; Smrkolj S; Rakar S; Stržinar V
    Stage IA cervical carcinoma: disease outcome of 566 cases
    2007
  87. Debevec Lučka
    Do patients have less thoracic pain from lobectomy compared to pneumonectomy?
    2007
  88. Tuohimaa P; Pukkala E; Scelo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V
    Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation
    2007
  89. Maule M; Scelo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; Pompe-Kirn V
    Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study
    2007
  90. Riska A; Pukkala E; Scelo G; Mellemkjaer L; Hemminki K; Weiderpass E; McBride ML; Pompe-Kirn V; Tracey E; Brewster DH
    Second primary malignancies in females with primary fallopian tube cancer
    2007
  91. Scelo G; Boffetta P; Corbex M; Chia KS; Hemminki K; Friis S; Pukkala E; Weiderpass E; McBride ML; Pompe-Kirn V
    Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries
    2007
  92. Richiardi L; Scelo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; Pompe-Kirn V
    Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries
    2007
  93. Španinger Klemen; Berne Sabina; Komel Radovan; Debeljak Nataša
    Recombinant human erythropoietin induced changes in signal transduction and gene expression in breast cancer patients
    2007
  94. Lah Tamara
    Proteases as targets in brain tumour progression
    2007
  95. Podgornik H; Debeljak M; Žontar D; Černelč P; Prestor VV; Jazbec J
    RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia
    2007
  96. Marty Michel; Serša Gregor; Snoj Marko; Miklavčič Damijan; Pavlović Ivan; Paulin-Košir Marija Snežna; Čemažar Maja; Rudolf Zvonimir
    Electrochemotherapy - an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases : results of ESOPE (European standard operating procedures of electrochemotherapy) study
    2006
  97. Snoj Marko; Rudolf Zvonimir; Paulin-Košir Marija Snežna; Čemažar Maja; Snoj Rudolf; Serša Gregor
    Long lasting complete response in melanoma treated by electrochemotherapy
    2006
  98. Serša Gregor
    The state-of-the-art of electrochemotherapy before the ESOPE study : advantages and clinical uses
    2006
  99. Mir Lluis Maria; Gehl J; Serša Gregor; Collins Christopher G.; Garbay JR; Billard Valérie; Geertsen PF; Rudolf Zvonimir; O'Sullivan Gerald C; Marty Michel
    Standard operating procedures of the electrochemotherapy : instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator TM by means of invasive or non-invasive electrodes
    2006
  100. Morales Leilani; Čufer Tanja
    Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer : a randomised phase III trial of the European Organis[!]ation for Research and Treatment of Cancer Breast Group
    2007

   1 101 201 301 401 501 601 701 801  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics